Mark Erlander

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 29% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mark Erlander's trades of Cardiff Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
444.26
Quantity 53,987 -39.8%
Value US$673,966
Transaction date
Purchase
Price
44.50
Quantity 31,724 +4.6%
Value US$1,302,688
Transaction date
Purchase
Price
297.38
Quantity 8,225 -44.7%
Value US$4,616,906
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-29 2022-11-25
B Purchase
53,987 -39.8%
444.26
US$673,966 		53,987 -39.8% 444.26 US$673,966
2021-03-23 2021-03-23
B Purchase
31,724 +4.6%
44.50
US$1,302,688 		31,724 +4.6% 44.50 US$1,302,688
2020-05-18 2020-05-14
B Purchase
8,225 -44.7%
297.38
US$4,616,906 		8,225 -44.7% 297.38 US$4,616,906